Belgium· BE-AMP-SAM577280-00
Glucosamin Owlpharma 400 mg
A glucosamine product containing glucosamine sulfate potassium chloride, registered in Belgium by Owlpharma-Consulting. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Glucosamine is registered in 14 of 19 countries.
Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Glucosamine · ATC M01AX05
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
Price per daily dose
What a daily dose of glucosamine costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Glucosamine · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$0.23
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Glucosamine Sulfate Potassium Chloride
- Manufacturer
- Owlpharma-Consulting
- Country
- Belgium (BE)
- ATC code
- M01AX05
- ATC class
- Glucosamine
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for glucosamine.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Glucosamine · interactions on record
2 records
- 2 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Glucosamine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Denmark · Glucosamin Copyfarm, Glucosamin Pharma Nord
- Estonia · Glucosamine Pharma Nord
- Finland · Glucosamin Pharma Nord
- Ireland · Glucosamine Pharma Nord
- Latvia · Glucosamine Pharma Nord
- Netherlands · Glucosamine Pharma Nord
- Norway · Glucosamin Pharma Nord
- Poland · Sanoflexan
- Slovenia · Glukozamin Pharma Nord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c025ff4a-69ea-4b87-8d23-42b2bad42c0a GET /v1/drugs/c025ff4a-69ea-4b87-8d23-42b2bad42c0a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Glucosamin Owlpharma 400 mg",
"name_fr": "Glucosamin Owlpharma 400 mg",
"name_nl": "Glucosamin Owlpharma 400 mg",
"amp_code": "SAM577280-00",
"strengths": [
"676.0000",
"676.0000",
"400.0000",
"400.0000"
],
"pack_count": 2,
"substances": [
"Glucosamine Sulfate Potassium Chloride",
"Glucosamine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Glucosamine",
"authorisation_numbers": [
"BE577280"
]
}See everything about glucosamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.